{"id":"https://openalex.org/W2145835848","doi":"https://doi.org/10.3109/10428194.2012.695779","title":"Off-target effects of BCR\u2013ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia","display_name":"Off-target effects of BCR\u2013ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia","alternate_titles":[],"publication_year":2012,"publication_date":"2012-06-18","ids":{"openalex":"https://openalex.org/W2145835848","doi":"https://doi.org/10.3109/10428194.2012.695779","mag":"2145835848","pmid":"https://pubmed.ncbi.nlm.nih.gov/22616642"},"language":"en","primary_location":{"id":"doi:10.3109/10428194.2012.695779","doi":"https://doi.org/10.3109/10428194.2012.695779","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428194.2012.695779","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145835848"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038000746","display_name":"Juan Luis Steegmann","orcid":"https://orcid.org/0000-0002-7799-5355","observed_orcids":["https://orcid.org/0000-0002-7799-5355"]},"institutions":[{"id":"https://openalex.org/I4210130498","display_name":"Hospital Universitario de La Princesa","ror":"https://ror.org/03cg5md32","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130498","https://openalex.org/I4210139293"]},{"id":"https://openalex.org/I4405259965","display_name":"Instituto de Investigaci\u00f3n Sanitaria del Hospital Universitario de La Princesa","ror":"https://ror.org/02zx68e15","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4405259965"]}],"countries":["ES"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Juan Luis Steegmann","raw_affiliation_strings":["Department of Hematology and Advanced Oncohematologic Therapies Group IIS-IP, Hospital Universitario de La Princesa, Madrid, Spain. jlsteegmann.hlpr@salud.madrid.org","Department of Hematology and Advanced Oncohematologic Therapies Group IIS-IP, Hospital Universitario de La Princesa, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Advanced Oncohematologic Therapies Group IIS-IP, Hospital Universitario de La Princesa, Madrid, Spain. jlsteegmann.hlpr@salud.madrid.org","institution_ids":["https://openalex.org/I4210130498","https://openalex.org/I4405259965"]},{"raw_affiliation_string":"Department of Hematology and Advanced Oncohematologic Therapies Group IIS-IP, Hospital Universitario de La Princesa, Madrid, Spain","institution_ids":["https://openalex.org/I4210130498","https://openalex.org/I4405259965"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018111458","display_name":"Francisco Cervantes","orcid":"https://orcid.org/0000-0003-2664-8131","observed_orcids":["https://orcid.org/0000-0003-2664-8131"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]},{"id":"https://openalex.org/I4210160192","display_name":"Consorci Institut D'Investigacions Biomediques August Pi I Sunyer","ror":"https://ror.org/054vayn55","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I4387153040","https://openalex.org/I4403928279"]},{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Francisco Cervantes","raw_affiliation_strings":["Hematology Department, Hospital Clinic, IDIBAPS University of Barcelona, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology Department, Hospital Clinic, IDIBAPS University of Barcelona, Barcelona, Spain","institution_ids":["https://openalex.org/I4210115097","https://openalex.org/I4210160192","https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038582279","display_name":"Philipp le Coutre","orcid":"https://orcid.org/0000-0003-4532-1097","observed_orcids":["https://orcid.org/0000-0003-4532-1097"]},"institutions":[{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Philipp le Coutre","raw_affiliation_strings":["Department of Hematology and Oncology, Campus Virchow Klinikum, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Oncology, Campus Virchow Klinikum, Charit\u00e9 Universit\u00e4tsmedizin, Berlin, Germany","institution_ids":["https://openalex.org/I7877124"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050873337","display_name":"Kimmo Porkka","orcid":"https://orcid.org/0000-0003-4112-5902","observed_orcids":["https://orcid.org/0000-0003-4112-5902"]},"institutions":[{"id":"https://openalex.org/I133731052","display_name":"University of Helsinki","ror":"https://ror.org/040af2s02","country_code":"FI","type":"education","lineage":["https://openalex.org/I133731052"]},{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kimmo Porkka","raw_affiliation_strings":["Department of Medicine, Helsinki University Central Hospital and Hematology Research Unit, University of Helsinki, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Helsinki University Central Hospital and Hematology Research Unit, University of Helsinki, Helsinki, Finland","institution_ids":["https://openalex.org/I133731052","https://openalex.org/I2800394112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019949455","display_name":"Giuseppe Nicola Saglio","orcid":"https://orcid.org/0000-0002-1046-3514","observed_orcids":["https://orcid.org/0000-0002-1046-3514"]},"institutions":[{"id":"https://openalex.org/I4210155833","display_name":"Ospedale San Luigi Gonzaga","ror":"https://ror.org/04nzv4p86","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210155833"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Giuseppe Saglio","raw_affiliation_strings":["Department of Internal Medicine and Hematology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine and Hematology, University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy","institution_ids":["https://openalex.org/I4210155833","https://openalex.org/I55143463"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5038000746"],"corresponding_institution_ids":["https://openalex.org/I4210130498","https://openalex.org/I4405259965"],"apc_list":null,"apc_paid":null,"fwci":1.176,"has_fulltext":false,"cited_by_count":121,"citation_normalized_percentile":{"value":0.74333801,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"53","issue":"12","first_page":"2351","last_page":"2361"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/bcr-abl1-inhibitor","display_name":"BCR-ABL1 inhibitor","score":0.8840000033378601},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9610000252723694},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.9399999976158142},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7480000257492065},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.9779999852180481},{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/dasatinib","display_name":"dasatinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/long-term-drug-safety","display_name":"long-term drug safety","score":0.6269999742507935},{"id":"https://openalex.org/keywords/drug-toxicity-mechanisms","display_name":"drug toxicity mechanisms","score":0.5}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.9505865573883057},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.9115505814552307},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.856563150882721},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7949955463409424},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.7816040515899658},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5919662714004517},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.5283287763595581},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5198698043823242},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4951263964176178},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.48048797249794006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3992893099784851},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.36181408166885376},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33277949690818787},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.11932730674743652},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05106225609779358}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000069439","descriptor_name":"Dasatinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003967","descriptor_name":"Diarrhea","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013844","descriptor_name":"Thiazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013921","descriptor_name":"Thrombocytopenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3109/10428194.2012.695779","doi":"https://doi.org/10.3109/10428194.2012.695779","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10428194.2012.695779","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia &amp; Lymphoma","raw_type":"journal-article"},{"id":"pmid:22616642","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22616642","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"},{"id":"pmh:oai:iris.unito.it:2318/137998","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2318/137998","pdf_url":null,"source":{"id":"https://openalex.org/S4306400637","display_name":"Institutional Research Information System University of Turin (University of Turin)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I55143463","host_organization_name":"University of Turin","host_organization_lineage":["https://openalex.org/I55143463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":108,"referenced_works":["https://openalex.org/W1487580790","https://openalex.org/W1927701703","https://openalex.org/W1963871766","https://openalex.org/W1971423532","https://openalex.org/W1971749359","https://openalex.org/W1975185750","https://openalex.org/W1975974764","https://openalex.org/W1976136448","https://openalex.org/W1976197008","https://openalex.org/W1977728980","https://openalex.org/W1983852790","https://openalex.org/W1987060661","https://openalex.org/W1990474652","https://openalex.org/W1991464577","https://openalex.org/W1991795177","https://openalex.org/W1994279776","https://openalex.org/W1996045366","https://openalex.org/W1996537616","https://openalex.org/W1997764773","https://openalex.org/W1998990808","https://openalex.org/W1999958515","https://openalex.org/W2000123759","https://openalex.org/W2000629172","https://openalex.org/W2000846629","https://openalex.org/W2003973314","https://openalex.org/W2005411117","https://openalex.org/W2005814885","https://openalex.org/W2008486345","https://openalex.org/W2009446375","https://openalex.org/W2010954840","https://openalex.org/W2011852093","https://openalex.org/W2012116939","https://openalex.org/W2013366836","https://openalex.org/W2014839361","https://openalex.org/W2018536353","https://openalex.org/W2019678391","https://openalex.org/W2024122208","https://openalex.org/W2026542427","https://openalex.org/W2026636495","https://openalex.org/W2027547216","https://openalex.org/W2028959752","https://openalex.org/W2031784543","https://openalex.org/W2033521825","https://openalex.org/W2035160863","https://openalex.org/W2036823605","https://openalex.org/W2037154482","https://openalex.org/W2039771828","https://openalex.org/W2050671905","https://openalex.org/W2051566553","https://openalex.org/W2053411009","https://openalex.org/W2057206328","https://openalex.org/W2061276786","https://openalex.org/W2061440903","https://openalex.org/W2063055656","https://openalex.org/W2067428197","https://openalex.org/W2073035156","https://openalex.org/W2076378952","https://openalex.org/W2077876030","https://openalex.org/W2080907164","https://openalex.org/W2081847353","https://openalex.org/W2087457069","https://openalex.org/W2090293697","https://openalex.org/W2091653492","https://openalex.org/W2092329640","https://openalex.org/W2093032646","https://openalex.org/W2093128301","https://openalex.org/W2093395043","https://openalex.org/W2093577878","https://openalex.org/W2093802822","https://openalex.org/W2094544760","https://openalex.org/W2097799776","https://openalex.org/W2097946794","https://openalex.org/W2099172974","https://openalex.org/W2100772783","https://openalex.org/W2101104783","https://openalex.org/W2103685844","https://openalex.org/W2114261707","https://openalex.org/W2114627676","https://openalex.org/W2119010176","https://openalex.org/W2120421624","https://openalex.org/W2122549521","https://openalex.org/W2124201452","https://openalex.org/W2124557535","https://openalex.org/W2126579741","https://openalex.org/W2130845505","https://openalex.org/W2133380474","https://openalex.org/W2139973222","https://openalex.org/W2140259730","https://openalex.org/W2143939343","https://openalex.org/W2150953357","https://openalex.org/W2158933399","https://openalex.org/W2160811827","https://openalex.org/W2161536876","https://openalex.org/W2168350703","https://openalex.org/W2168633862","https://openalex.org/W2261840157","https://openalex.org/W2289194569","https://openalex.org/W2523356314","https://openalex.org/W2536038858","https://openalex.org/W2552007180","https://openalex.org/W2559030244","https://openalex.org/W2566863760","https://openalex.org/W2567264821","https://openalex.org/W2567307782","https://openalex.org/W2587261774","https://openalex.org/W2590231153","https://openalex.org/W2590322037","https://openalex.org/W2979381504"],"related_works":["https://openalex.org/W3150954884","https://openalex.org/W2116887545","https://openalex.org/W1800349813","https://openalex.org/W3181733357","https://openalex.org/W2314704099","https://openalex.org/W1965493606","https://openalex.org/W2507430173","https://openalex.org/W2086747176","https://openalex.org/W2142609621","https://openalex.org/W287273090"],"abstract_inverted_index":{"In":[0],"patients":[1,57,147],"with":[2,58,116,136,148],"chronic":[3,109],"myeloid":[4],"leukemia":[5],"(CML),":[6],"use":[7],"of":[8,32,41,70,78,108,130,143],"the":[9,75,91,105,117,123,131,140],"BCR-ABL1-specific":[10],"tyrosine":[11],"kinase":[12],"inhibitors":[13,62],"(TKIs)":[14],"imatinib,":[15],"nilotinib":[16,44],"and":[17,24,38,45,67,104,125,138],"dasatinib":[18,46],"has":[19],"greatly":[20],"improved":[21],"patient":[22],"survival":[23],"prolonged":[25],"disease":[26],"remission.":[27],"More":[28],"than":[29],"10":[30],"years":[31,40],"data":[33,42,127],"from":[34],"imatinib":[35],"clinical":[36,126],"studies":[37],"many":[39],"for":[43,74,128,146],"have":[47],"demonstrated":[48],"that":[49,87,96],"these":[50,61,79,99,144],"TKIs":[51,137],"are":[52,63,84,88,101],"well":[53],"tolerated":[54],"in":[55],"most":[56],"CML.":[59,149],"However,":[60],"not":[64],"entirely":[65],"BCR-ABL1-specific,":[66],"this":[68],"lack":[69],"specificity":[71],"could":[72],"account":[73],"off-target":[76,85],"effects":[77,86,100],"drugs.":[80],"Adverse":[81],"events":[82],"(AEs)":[83],"detrimental":[89],"to":[90,98],"patient.":[92],"The":[93],"underlying":[94],"mechanisms":[95],"contribute":[97],"poorly":[102],"understood":[103],"long-term":[106],"consequences":[107],"TKI":[110],"therapy":[111],"remain":[112],"largely":[113],"unknown,":[114],"particularly":[115],"newer":[118],"agents.":[119],"Here,":[120],"we":[121],"review":[122],"preclinical":[124],"several":[129],"more":[132],"frequent":[133],"AEs":[134,145],"associated":[135],"discuss":[139],"therapeutic":[141],"relevance":[142]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145835848","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
